MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$9,800K
Free Cash flow
$66,700K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Cash received from customers
Proceeds from sale of debt secur...
Proceeds from maturities of mark...
Others
Negative Cash Flow Breakdown
Cash paid to suppliers and emplo...
Payments for purchases of market...
Capital expenditures
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash received from customers
628,600
614,100
697,700
653,800
Cash paid to suppliers and employees
538,800
515,800
547,500
517,500
Interest paid, net
900
22,400
1,100
22,400
Income tax payments, net
13,300
11,000
7,300
-1,800
Investment proceeds and miscellaneous receipts, net
15,700
33,300
18,300
13,800
(payments for) proceeds from forward foreign exchange contracts, net
-
-
-38,100
-
Proceeds from forward foreign exchange contracts, net
-7,400
-52,800
-
8,600
Net cash provided by operating activities
98,700
108,100
164,900
120,900
Capital expenditures
32,000
30,000
45,800
31,700
Proceeds from dispositions of property, plant and equipment
-100
100
0
0
Proceeds from divestiture of a division
-
-
0
-
Payments for business acquisitions, net of cash received
-
-
0
1,800
Payments for acquired in-process research and development
-
-
0
0
(payments for) proceeds from acquisitions, net of cash received
-1,100
-
-
-
Payments for purchases of marketable securities and investments
184,200
226,100
138,800
223,900
Proceeds from sale of debt securities, available-for-sale
126,800
145,100
147,400
200,600
Proceeds from maturities of marketable securities and investments
21,700
17,700
3,000
13,800
Net cash used in investing activities
-66,700
-93,200
-34,200
-43,000
Payments on long-term borrowings
200
100
200
0
Payments for debt issuance costs
-
-
0
0
Proceeds from issuance of common stock and from reissuance of treasury stock under the employee stock purchase plan and upon exercise of stock options
-
-
15,800
-
Proceeds from issuance of common stock
4,200
-8,500
-
3,400
Tax payments from net share settlement
100
-
400
2,500
Payments for purchases of treasury stock
31,500
47,800
0
53,400
Payments of contingent consideration
-
-
0
-
Option premium proceeds for structured purchases of treasury stock
0
500
-
-
Net cash used in financing activities
-27,600
-44,000
3,300
-52,500
Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash
-
-
-16,900
-
Effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents
5,400
22,800
-
1,100
Cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect
9,800
-23,200
134,000
26,500
Beginning cash, cash equivalents, and restricted cash
509,000
532,200
398,200
489,800
Ending cash, cash equivalents, and restricted cash
518,800
509,000
532,200
398,200
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Cash received from
customers
$628,600K
(-51.83%↓ Y/Y)
Investment proceeds and
miscellaneous receipts, net
$15,700K
(-67.89%↓ Y/Y)
Proceeds from forward
foreign exchange...
-$7,400K
(-121.57%↓ Y/Y)
Net cash provided by
operating activities
$98,700K
(-59.94%↓ Y/Y)
Effect of exchange rate
on cash, cash...
$5,400K
(130.00%↑ Y/Y)
Canceled cashflow
$553,000K
Cash, cash
equivalents, restricted cash...
$9,800K
(108.30%↑ Y/Y)
Canceled cashflow
$94,300K
Cash paid to
suppliers and employees
$538,800K
(-45.79%↓ Y/Y)
Income tax payments,
net
$13,300K
(-76.29%↓ Y/Y)
Interest paid, net
$900K
(-96.10%↓ Y/Y)
Proceeds from sale of debt
securities,...
$126,800K
(-71.54%↓ Y/Y)
Proceeds from maturities
of marketable...
$21,700K
(-51.99%↓ Y/Y)
(payments for) proceeds
from acquisitions,...
-$1,100K
Proceeds from issuance of
common stock
$4,200K
(-50.59%↓ Y/Y)
Net cash used in
investing activities
-$66,700K
(40.71%↑ Y/Y)
Net cash used in
financing activities
-$27,600K
(88.21%↑ Y/Y)
Canceled cashflow
$149,600K
Canceled cashflow
$4,200K
Payments for purchases of
marketable securities and...
$184,200K
(-39.92%↓ Y/Y)
Payments for purchases of
treasury stock
$31,500K
(-86.99%↓ Y/Y)
Capital expenditures
$32,000K
(-60.05%↓ Y/Y)
Proceeds from
dispositions of property,...
-$100K
(-200.00%↓ Y/Y)
Payments on long-term
borrowings
$200K
(-33.33%↓ Y/Y)
Tax payments from
net share...
$100K
(0.00%↑ Y/Y)
Buy us a coffee
BIO-RAD LABORATORIES, INC. (BIO)
BIO-RAD LABORATORIES, INC. (BIO)